NDC 0206-8852-08
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0206-8852
- Requested NDC
- 0206-8852-08
- Package NDCs from labels
- 0206-8852-08
- Manufacturer
- National Council for Prescription Drug Programs
- Effective date
- 2012-07-24
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0206-8852-08 | EA - Each | 0206-8852 | f2d90ad0-200c-4d01-8c2c-e936a672c168 | 1 | 2012-07-24 |
| 0206-8852-16 | EA - Each | 0206-8852 | e563a157-8efd-48b7-9a0e-b3aa70c4ecf1 | 1 | 2012-07-24 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Piperacillin and Tazobactam | PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM | Fresenius Kabi USA, LLC | e53ebafc-3afa-4a1e-9313-fecd1c1c5d7c | 2024-10-16 | Boxed warning, Warnings, Adverse reactions | PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM |
| Piperacillin and Tazobactam | PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM | Fresenius Kabi USA, LLC | 2cfa6723-175b-4c4d-8212-266844b07610 | 2024-10-16 | Boxed warning, Warnings, Adverse reactions | PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM |
| Piperacillin and Tazobactam | PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM | Fresenius Kabi USA, LLC | c78e0931-ec79-58e5-8658-7fe692dc3b8b | 2024-10-16 | Boxed warning, Warnings, Adverse reactions | PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM |
| Piperacillin and Tazobactam | PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM | Eugia US LLC | 80f4bdb8-131e-4485-b7a2-accd596d4cde | 2024-09-04 | Warnings, Adverse reactions | PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM |
| Zosyn in Galaxy Containers | TAZOBACTAM SODIUM AND PIPERACILLIN SODIUM | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | 8ab9d90d-2f7f-4599-a44f-3d0a8f8ab623 | 2023-03-15 | Warnings, Adverse reactions | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. |
| North American Coral Snake Antivenin (Equine) | CORAL SNAKE (MICRURUS FULVIUS) IMMUNE GLOBULIN ANTIVENIN (EQUINE) | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | 6d0f94b4-82ca-37c7-edb0-4f0702cf6c8d | 2022-11-22 | Warnings, Adverse reactions | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.